Tomlinson I, Ilyas M, Johnson V, Davies A, Clark G, Talbot I, Bodmer W
Cancer Genetics Laboratory, Imperial Cancer Research Fund, London, U.K.
J Pathol. 1998 Feb;184(2):148-52. doi: 10.1002/(SICI)1096-9896(199802)184:2<148::AID-PATH986>3.0.CO;2-M.
Patterns of allele loss (loss of heterozygosity, LOH) have been studied in order to investigate the genetic pathways involved in the pathogenesis of three types of colorectal cancer (CRC): sporadic CRC without replication errors (RER-) (32 cases); sporadic RER+ CRC (23 cases); and ulcerative colitis-associated CRC (UCACRC) (16 cases). Each tumour was assessed for allele loss at ten microsatellite markers which map close to known or putative tumour-suppressor genes: APC (5q21-q22); DCC (18q21.1); 1p35-p36; p16 (9p21); 22q; 8p; E-cadherin (16q22.1); beta-catenin (3p22-p21.3); RB1 (13q14.1-q14.2); and HLA. Overall, high frequencies of allele loss (> 30 per cent) were found near DCC (42 per cent), p16 (38 per cent), 22q (37 per cent), 1p35-p36 (34 per cent) and APC (31 per cent), and low frequencies (< 20 per cent) near RB1 (16 per cent) and E-cadherin (13 per cent). LOH near beta-catenin, HLA, and on 8p occurred at frequencies between 20 and 30 per cent. The overall frequency of allele loss did not differ among the three tumour groups, but some variation was seen at individual loci. There was a significantly higher frequency of LOH at 1p35-36 in RER+ tumours compared to RER- tumours. Allele loss at this site was also associated with a more advanced Dukes' stage at presentation. In addition, RER- tumours showed a higher frequency of allele loss at p16 than RER+ tumours. No significant difference existed at any locus between the frequency of LOH in sporadic CRC and in UCACRC. Pairwise analysis showed a negative association between LOH at APC and DCC, and between LOH at chromosome 22p and p53 overexpression. Thus, there may be specific differences between the mutation spectra of RER+ and RER- CRCs, but there are large degrees of overlap among the underlying genetic pathways of these cancers and UCACRCs.
为了研究参与三种类型结直肠癌(CRC)发病机制的遗传途径,对等位基因缺失模式(杂合性缺失,LOH)进行了研究:无复制错误的散发性CRC(RER-)(32例);散发性RER+ CRC(23例);以及溃疡性结肠炎相关CRC(UCACRC)(16例)。对每个肿瘤在十个微卫星标记处评估等位基因缺失情况,这些标记位于已知或假定的肿瘤抑制基因附近:APC(5q21-q22);DCC(18q21.1);1p35-p36;p16(9p21);22q;8p;E-钙黏蛋白(16q22.1);β-连环蛋白(3p22-p21.3);RB1(13q14.1-q14.2);以及HLA。总体而言,在DCC(42%)、p16(38%)、22q(37%)、1p35-p36(34%)和APC(31%)附近发现了高频率的等位基因缺失(>30%),而在RB1(16%)和E-钙黏蛋白(13%)附近发现了低频率的等位基因缺失(<20%)。β-连环蛋白、HLA附近以及8p上的LOH发生频率在20%至30%之间。三个肿瘤组之间等位基因缺失的总体频率没有差异,但在个别位点存在一些变化。与RER-肿瘤相比,RER+肿瘤中1p35-36处的LOH频率显著更高。该位点的等位基因缺失也与就诊时更晚期的杜克分期相关。此外,RER-肿瘤中p16处的等位基因缺失频率高于RER+肿瘤。散发性CRC和UCACRC中LOH频率在任何位点均无显著差异。成对分析显示APC和DCC处的LOH之间以及22p处的LOH与p53过表达之间呈负相关。因此,RER+和RER- CRC的突变谱之间可能存在特定差异,但这些癌症和UCACRC的潜在遗传途径之间存在很大程度的重叠。